<SEC-DOCUMENT>0001104659-23-056921.txt : 20230508
<SEC-HEADER>0001104659-23-056921.hdr.sgml : 20230508
<ACCEPTANCE-DATETIME>20230508091211
ACCESSION NUMBER:		0001104659-23-056921
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230508
DATE AS OF CHANGE:		20230508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ProMIS Neurosciences Inc.
		CENTRAL INDEX KEY:			0001374339
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-268103
		FILM NUMBER:		23896110

	BUSINESS ADDRESS:	
		STREET 1:		SUITE 200, 1920 YONGE STREET
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M4S 3E2
		BUSINESS PHONE:		416-847-6898

	MAIL ADDRESS:	
		STREET 1:		SUITE 200, 1920 YONGE STREET
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M4S 3E2

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMORFIX LIFE SCIENCES LTD
		DATE OF NAME CHANGE:	20060831
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>tm2314973d1_424b3.htm
<DESCRIPTION>424B3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed pursuant to Rule&nbsp;424(b)(3)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No.&nbsp;333-268103</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PROSPECTUS&nbsp;SUPPLEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(To Prospectus dated November&nbsp;8, 2022)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="tm2314973d1_424b3img01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROMIS NEUROSCIENCES&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to 1,383,755 Common Shares Underlying Units</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to 345,939 Common Shares Underlying Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Prospectus Supplement
No.&nbsp;06 (this &#8220;<B>Prospectus Supplement</B>&#8221;) amends and supplements the Prospectus dated November&nbsp;8, 2022 (the &#8220;<B>Prospectus</B>&#8221;)
of ProMIS Neurosciences Inc. (the &#8220;<B>Company</B>&#8221;), which forms a part of our Registration Statement on Form&nbsp;S-1 (Registration
No.&nbsp;333-268103) (our &#8220;<B>Registration Statement</B>&#8221;). This Prospectus Supplement is being filed to amend and supplement
the information included or incorporated by reference in the Prospectus with the information contained in this Prospectus Supplement.
The Prospectus and this Prospectus Supplement relate to the resale by the selling security holders named in the Prospectus (the &#8220;<B>Selling
Shareholders</B>&#8221;) of up to an aggregate of 1,729,694 of our common shares, no par value (&#8220;<B>common shares</B>&#8221;), which
consists of (i)&nbsp;up to 1,383,755 common shares that are issuable to certain of the Selling Shareholders that are party to the Unit
Purchase Agreement, dated October&nbsp;11, 2022 (the &#8220;<B>Unit Purchase Agreement</B>&#8221;); and (ii)&nbsp;up to 345,939 common
shares that are issuable to certain of the Selling Shareholders that are party to the Unit Purchase Agreement upon the exercise of warrants
to purchase our common shares that we issued to Selling Shareholders in a private placement that closed in connection with the Unit Purchase
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Prospectus Supplement
includes information from our Report on Form&nbsp;8-K filed on May 8, 2023 reporting clearance by the U.S. Food and Drug Administration
of an Investigational New Drug application to the U.S. Food and Drug Administration for PMN310 for the treatment of Alzheimer&#8217;s
disease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Prospectus Supplement
should be read in conjunction with the Prospectus that was previously filed, except to the extent that the information in this Prospectus
Supplement updates and supersedes the information contained in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Investing in our securities
involves risks that are described in the &#8220;Risk Factors&#8221; section beginning on page&nbsp;12 of the Prospectus.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Neither the U.S. Securities
and Exchange Commission (the &#8220;SEC&#8221;), nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this Prospectus Supplement is May 8,
2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2314973d1_424b3img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2314973d1_424b3img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !) ,P# 2(  A$! Q$!_\0
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M>VE[;AAMN+6X65S%<1-)$[*Z;_,CD1/4_P!C7XT>!?@M^T9\._%6@>#-:O\
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M<+7P[P,G*M5HUI87,\/*O.A"%.5L)&I4B_8RD_TG$>"'$5+),1A,VPV<0SS
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M/CU\4-4\8_&_Q[X?O_#4/BSP_<W>F6_@O3[JRM[*"X\/RJEK=G4[2*QM8DF
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
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
